Predictive Diagnostics

Matrix Medical Network Partners with Molecular Testing Labs to Expand In-Home Diagnostic Capabilities

Collaboration aims to improve access to advanced lab testing through at-home services, supporting earlier detection and personalized care delivery....

Seegene Debuts World’s First Fully Unattended PCR Automation at ADLM 2025

Breakthrough system set to revolutionize molecular diagnostics by enabling 24/7 sample-to-result PCR testing with no human intervention....

Scopio Labs Launches World’s First Fully Automated AI Blood Morphology System

Breakthrough technology aims to transform hematology diagnostics by combining full-field imaging and AI-driven analysis for faster, more accurate results....

Olympus Forms Strategic Partnership to Advance GI Robotics Innovation

Collaboration aims to develop next-generation endoluminal robotic platforms for enhanced precision and minimally invasive interventions in gastrointestinal care....

Geneoscopy Secures FDA Approval for New At-Home Stool Collection Method

Simplified Process Aims to Boost Participation in Colorectal Cancer Screening and Improve Early Detection Rates...

Hyperfine Showcases Swoop® AI-Powered Portable MRI in Dementia Care Studies

Clinical research highlights the potential of Hyperfine’s portable brain imaging system to improve early diagnosis and expand access to neuroimaging in underserved dementia populations....

Rebuilding the Drug Repurposing Pipeline with Better Data

How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development. ...

Hesperos Unveils First Digital Twin of Human Disease with Organ-on-a-Chip Breakthrough

Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine....

Canada Grants Patent to bioAffinity Technologies for CyPath® Lung Diagnostic Test

New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets ...

SkylineDx's Merlin Melanoma Assay Validated to Reduce Sentinel Lymph Node Biopsies by Over 40%

Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...